local_hospital

Bajai Szent Rokus Korhaz

Address
lock Available on a paid plan

Cardiovascular Diseases

Clinical research at Bajai Szent Rokus Korhaz includes studies in cardiovascular diseases focused on people with established atherosclerotic cardiovascular disease and other forms of cardiovascular disease. These trials are designed to test new treatment approaches that may help reduce the risk of major heart and stroke-related events and improve long-term outcomes.

  • Evaluating therapies aimed at lowering the risk of major adverse cardiovascular events
  • Studying treatments for patients with established atherosclerotic cardiovascular disease
  • Assessing long-term safety and tolerability of lipid-related cardiovascular therapies

The site’s work in this area reflects a strong interest in preventing serious complications through better cardiovascular risk reduction and treatment effectiveness.

Bacterial Infections and Mycoses

The hospital also participates in research on bacterial infections, with a focus on preventing post abdominal surgery incisional infection. This area of study is centered on improving infection control after surgery and evaluating whether new supportive approaches can reduce surgical site infections alongside standard care.

  • Preventing surgical site infections after abdominal surgery
  • Testing anti-infective strategies used with standard postoperative care
  • Improving safety and infection prevention in surgical patients

These studies support better recovery after surgery and add to the clinical understanding of infection prevention in hospital-based care.

Site Overview

assignment
7
connected trials
corporate_fare
5
sponsors
science
11
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
7
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
5
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
7
Outperforms 64% of sites
public
Therapeutic diversity
4areas
Outperforms 76% of sites
groups
Sponsor diversity
5sponsors
Outperforms 65% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Bajai Szent Rokus Korhaz

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV DiseaseMerck Sharp & Dohme LLCPhase IIINot RecruitingNov 2021Jun 2025

IMP list

lock Showing 1 of 11 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Pelacarsen2Unknown2020-03-062026-05-11

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.